Life Sciences

KV Pharmaceutical enters into consent decree with FDA

Pharma Compliance Alert, March 4, 2009

KV Pharmaceutical may soon resume manufacturing and marketing products after entering into a consent decree with the FDA, the company announced.

On January 28, KV recalled more than 80 medications distributed by its subsidiaries Ther-Rx and ETHEX as a precautionary measure because the products may have been manufactured under conditions that did not met current Good Manufacturing Practices (cGMP).

Read more about KV's consent decree with the FDA.

Most Popular

Related Articles